Restless Legs Syndrome and Erectile Dysfunction

Transcription

1 restless legs syndrome and erectile dysfunction Restless Legs Syndrome and Erectile Dysfunction Xiang Gao, MD, PhD 1,2 ; Michael A. Schwarzschild, MD, PhD 3 ; Eilis J. O Reilly, ScD 2 ; Hao Wang, MD, PhD 2 ; Alberto Ascherio, MD, DrPH 1,2 1 Channing Laboratory, Department of Medicine, Brigham and Women s Hospital, and Harvard Medical School, Boston, MA; 2 Harvard University School of Public Health, Boston, MA; 3 Department of Neurology, Massachusetts General Hospital, Boston, MA Study Objectives: Dopaminergic hypofunction in the central nervous system may contribute to restless legs syndrome () and erectile dysfunction (ED). We therefore examined whether men with have higher prevalences of ED. Design: was assessed using a set of standardized questions. Men were considered to have if they met 4 diagnostic criteria recommended by the International Study Group, and had restless legs 5 times/month. Erectile function was assessed by a questionnaire. Setting: Community-based. Participants: 23,119 men who participated in the Health Professional Follow-up Study free of diabetes and arthritis. Results: Multivariate-adjusted odds ratios for ED were 1.16 and 1.78 (95% confidence interval: 1.4, 2.3; P trend < ) for men with symptoms 5 14 times/mo, and 15+ times/mo, respectively, relative to those without, after adjusting for age, smoking, BMI, antidepressant use, and other covariates. The associations between and ED persisted in subgroup analysis according to age, obesity, and smoking status. Conclusions: Men with had a higher likelihood of concurrent ED, and the magnitude of the observed association was increased with a higher frequency of symptoms. These results suggest that ED and share common determinants. Keywords: Restless legs syndrome, erectile function, men Citation: Gao X; Schwarzschild MA; O Reilly EJ; Wang H; Ascherio A. Restless legs syndrome and erectile dysfunction. SLEEP 2010;33(1): Restless legs syndrome () is a generally underdiagnosed and undertreated neurological disorder characterized by a complaint of an almost irresistible urge to move the legs, affecting 5% to 15% of adults. 1,2 has a substantial impact on sleep, daily activities, and quality of life. 1 Although the etiology of is still unclear, dopaminergic hypofunction in the central nervous system (CNS) is believed to have a role in disease pathophysiology. 3 This hypothesis has been supported by evidence that symptoms were improved by administration of L-dopa 4 or dopamine agonist 5-7 ; and that dopamine antagonists that cross the blood-brain-barrier (BBB) (e.g., metoclopramide and pimozide) and exacerbate symptoms, whereas those that do not cross the BBB (e.g., domperidone) do not have an effect on. 3,8,9 Dopamine in the CNS plays important role in regulation of erectile function. 10,11 In a previous study, we found that men with erectile dysfunction (ED) were ~4 times more likely to develop Parkinson disease during 16 years follow-up, another disorders associated with dopamine hypofunction in the CNS, than those who reported normal erectile function. 12 It is thus of interest to investigate whether patients have a higher risk of ED. This association, however, has not been previously investigated. We, therefore, conducted a cross-sectional analysis to examine whether men with have a higher likelihood of having ED in the Health Professional Follow-up Study (HPFS), a large ongoing US cohort of men. Submitted for publication March, 2009 Submitted in final revised form October, 2009 Accepted for publication October, 2009 Address correspondence to: Dr. Xiang Gao, Channing Laboratory, Department of Medicine, Brigham and Women s Hospital, and Harvard Medical School, 181 Longwood Ave, Boston, MA; Tel: (617) ; Fax: (617) ; xiang.gao@channing.harvard.edu SLEEP, Vol. 33, No. 1, MATERIALS AND METHODS Study Populations The HPFS was established in 1986, when 51,529 male US health professionals (dentists, optometrists, osteopaths, podiatrists, pharmacists, and veterinarians) aged years completed a mailed questionnaire about their medical history and lifestyle. Follow-up questionnaires have been mailed to participants every 2 years to update information on potential risk factors and to ascertain newly diagnosed diseases in both cohorts. The institutional review board at Brigham and Women s Hospital reviewed and approved this study, and receipt of each questionnaire implies participant s consent. Assessment of We asked questions about diagnosis and severity based on the International Study Group criteria in 2002 (n = 37,431, mean age 68.7 ± 9 y) among participants who were still alive and actively participating in the study. 13 The following question was asked: Do you have unpleasant leg sensations (like crawling, paraesthesia, or pain) combined with motor restlessness and an urge to move? The possible responses were as follows: no; less than once/month; 2-4 times/month; 5-14 times/month; and 15 or more times per month. Those who answered that they had these feelings were asked the following 2 questions: (1) Do these symptoms occur only at rest and does moving improve them? ; and (2) Are these symptoms worse in the evening/night compared with the morning? A probable case was considered to be present if the participant answered yes for all 3 of the above questions with a frequency 5 times/month. The questions on were completed by 31,729 (85%) men. Men who did not complete the questions had similar age (mean 69.0 vs years) and prevalence of ED (44.8% vs. 43.9%) as those with information. To reduce possible misclassification of, we excluded participants with diabe-

2 tes and arthritis, leaving 23,119 men in primary analyses. In a secondary analysis, we further examined the association between and ED with including all participants with information. Assessment of ED and Covariates On the 2000 and 2004 questionnaire, we asked HPFS participants who were still alive and actively participating in the study to rate their ability to have and maintain an erection sufficient for intercourse. There were 5 possible responses: very poor, poor, fair, good, and very good. Reports of poor or very poor erectile function in or prior to 2004 were considered ED, as we did previously. 12,14 % of Erectile dysfunction Without With < Age group in 2002, y Figure 1 Prevalence of erectile dysfunction (ED) by restless legs syndrome status. Information on potential confounders, including age, ethnicity, smoking status, weight, height, physical activity, use of medicines, phobic anxiety scale, and history of major chronic diseases, was collected via biennial questionnaires throughout the follow-up period. Body mass index (BMI) was calculated as weight (kg)/ height (m) 2. The phobic anxiety scale was assessed by the Crown-Crisp phobia index, a short, clinical self-rating scale for common phobias such as fear of enclosed spaces, illness, going out alone, heights, and crowds. 15,16 Anxiety has been shown to be associated with and ED Statistical Analyses Statistical analyses were completed with SAS version 9.1 (SAS Institute, Inc, Cary, NC). We categorized participants into 3 groups: no, with symptom 5-14 times/mo, and with symptom 15+ times/mo. Logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs) and to test differences in prevalence of ED across categories of status. Analyses were adjusted for age (y), ethnicity (Caucasian, African American, and Asian and others), BMI ( < 23, , , , or 30 kg/m 2 ), smoking (never smoked, former smoker, or current smoker: cigarettes/d, 1-14 or 15), physical activity (quintiles), use of antidepressants (yes/no), the Crown-Crisp phobic anxiety index (0-1, 2, 3, or 4), and presence of stroke, hypertension, or myocardial infarction (each of them, yes/no). We examined potential interactions of presence of (yes/ no) with age ( < or 70 years, approximate median value), obesity (yes/no, based on BMI 30 kg/m 2 ), and smoking status (never versus ever), by including multiplicative terms in the logistic regression models, with adjustment for other potential confounders. Table 1 Basic characteristics according to restless legs syndrome status in 2002 in the Health Professionals Follow-up Study* Restless legs syndrome status in 2002 No 5-14 times/mo 15+ times/mo n Age, y Current smokers, % Past smokers, % African Americans, % Asian & other ethnicity, % BMI, kg/ m Physical activity, Mets/wk Phobic anxiety index Use of antidepressant, % Presence of stroke in or prior to , % Presence of hypertension in or prior to 2002, % Presence of myocardial infarction in or prior to 2002, % *Values were standardized to the age distribution of the overall cohort. SLEEP, Vol. 33, No. 1, RESULTS Men with were older; they were more likely to be white, to smoke, exercise less, and use antidepressants than participants without. Men with also had higher BMI, anxiety score, and prevalence of stroke and hypertension than participants without (Table 1). As expected, the prevalence of ED increased with age (Figure 1). However, men with had higher prevalence of ED than those without in each age group. Up to 2004, 52.9% of patients reported erectile dysfunction, relative to 40.3% of participants without (age-adjusted OR = 1.47; 95% CI: 1.3, 1.7). Higher frequency of symptom, a marker for the disease severity, was associated with increased risk of having ED (Table 2). The ORs for ED were 1.16 and 1.78 (95% CI: 1.4, 2.3; P for trend < ) for men with symptom of 5-14 times/ mo, and 15+ times/mo, respectively, relative to those without, after adjusting for age, BMI, use of antidepressants, and other covariates. The significant association with ED was not materially altered after excluding men with Parkinson disease, which is also associated with dopamine deficiency (Table 2).

3 To test the robustness of our observations, we conducted several sensitivity analyses and obtained similar significant results. Multiple-adjusted ORs comparing the men with symptom 15+ times/mo with those without were 1.74 (95% CI: 1.3, 2.3) for ED after excluding participants with highest levels of phobic anxiety, 1.81 (95% CI: 1.4, 2.3) after excluding participants with MI or stroke, and 1.68 (95% CI: 1.2, 2.3) after excluding those with hypertension. Excluding participants who used antidepressant did not materially change the associations between and ED; adjusted ORs comparing the men with symptoms 15+ times/mo with those without were 1.80 (95% CI:1.4, 1.8). After further inclusion of participants with diabetes or arthritis, association between and ED did not change. The multiple-adjusted ORs comparing men with symptoms 15+ times/mo with men without were 1.75 (95% CI: 1.5, 2.1). We did not find significant interaction between presence of and age, obesity, and smoking status (P interaction > 0.2 for all), in relation to likelihood of having ED (Table 3). The associations between and ED persisted in subgroup analysis according to age, obesity, and smoking status. Further, the interactions between presence of and antidepressant use were also not significant (P interaction = 0.67). DISCUSSION In this large cohort of men, we observed that men with had higher prevalences of ED, relative to those without, across all age groups. Magnitude of the association was positive associated with frequency (i.e., severity) of ; men who reported to have symptoms 15+ times/month had an approximately two-fold higher risk of having ED as with men without. The associations were independent of age, BMI, use of antidepressants, anxiety, and other possible risk factors for. Sensitivity and subgroup analyses also generated similar significant results, suggesting robustness of our findings. We found that 4.1% of men met 4 diagnostic criteria recommended by the International Study Group, and had restless legs 5 times/mo. This prevalence is consistent with previous studies. In a large population-based survey including 16,202 adults aged 18 y living in the US and 5 European countries, 20 5% of participants had symptoms 1 times/ wk and 4.1% 2 times/wk. In a recent community-based study including 1730 men and 2101 women (mean age 68 y), prevalence of was 6.4% in women and 3.4% in men. 21 In this study, was defined as meeting all 4 diagnostic criteria, with symptoms occurring 5 times/mo and associated with at least moderate distress. A French study also reported that 4.3% men and women (aged 18 y) with symptoms 1 time/wk. 22 Table 2 Odds ratios (ORs) and 95% confidence interval (CI) of erectile dysfunction according to restless legs syndrome status in the Health Professional Follow-up Study No 5-14 times/mo (n = 549) 15+ times/mo (n = 395) (n = 22175) Erectile dysfunction # cases Age adjusted OR 1 (ref.) 1.22 (1.01, 1.48) 1.93 (1.53, 2.43) < Multivariate adjusted OR 1 1 (ref.) 1.16 (0.95, 1.40) 1.78 (1.40,2.25) < Excluding men with Parkinson s disease P trend 1 (ref.) 1.18 (0.97, 1.43) 1.76 (1.39,2.23) < Logistic regression models were used to calculate ORs, adjusted for age (in years); smoking status (never smoker, former smoker, or current smoker: cigarettes/d, 1-14 or 15); BMI (< 23, , , , or 30 kg/ m 2 ); use of antidepressant drugs (yes/no); physical activity (quintiles); the Crown-Crisp phobic anxiety index (0-1, 2, 3, or 4); and presence of stroke, hypertension, or myocardial infarction (each of them, yes/no) Table 3 Odds ratios (ORs) and 95% confidence interval of erectile dysfunction according to presence of restless legs syndrome (), stratified by age, smoking status, and BMI OR 1 for erectile dysfunction No P interaction Age < 70 y 1 (ref) 1.31 (1.07,1.61) y 1 (ref) 1.49 (1.19, 1.87) Smoking Never 1 (ref) 1.41 (1.11,1.81) 0.76 Ever 1 (ref) 1.35 (1.11,1.63) BMI < 30 kg/m 2 1 (ref) 1.34 (1.05,1.70) kg/m 2 1 (ref) 1.39 (1.15, 1.69) 1 Logistic regression models were used to calculate ORs, adjusted for age (in years); smoking status (never smoker, former smoker, or current smoker: cigarettes/d, 1-14 or 15); BMI (< 23, , , , or 30 kg/m 2 ); physical activity (quintiles); the Crown-Crisp phobic anxiety index (0-1, 2, 3, or 4); and presence of stroke, hypertension, or myocardial infarction (each of them, yes/no) Although there are no studies examining the association between and erectile function directly, a case-control study showed that was associated with reduced libido; the multivariate adjusted OR for reduced libido was 2.2 (95% CI: 1.4, 3.3) for men with vs. controls. 23 The mechanisms underlying the observed association between and ED could involve multiple pathways. Hypofunction of dopamine in CNS, which is associated with both conditions, could, at least in part, explain the association. Dopamine and its agonists control penile erection via activation of oxytocinergic neurons in the hypothalamus. L-DOPA and apomorphine, a dopaminergic agonist used to improve symptoms, can elicit erection, 10,11,24,25 and the pro-erectile effects of these drugs have been abolished by administration of dopamine antagonist. 26 In an animal model of, 6-hydroxydopamine lesions in the A11 dopamine nuclei increased locomotor activities and SLEEP, Vol. 33, No. 1,

4 altered the dopamine D2/D3 receptors expression and binding capacity in the lumbar spinal cord. 27 In genetic studies, people with LBXCOR1 mutation, a gene involved development of spinal cord, were found to have a higher risk of. 28 The spinal cord also plays a key role in sexual function and subjects with spinal cord injuries have a higher prevalence of sexual dysfunction. 29 Further, periodic limb movement disorder, a key feature of which is generated in the spinal cord, was found to be associated ED in a case-control study. 30 The association between and ED could also partially due to other sleep disorders which co-occur with. These disorders may affect the hormonal, neural and endothelial physiology, 31 and may therefore contribute to increased risk of sexual dysfunction For example, obstructive sleep apnea and sleep deprivation may decrease circulating testosterone levels. 31 Several other chronic conditions could also underlie the association between and ED. For example, cardiovascular diseases and obesity are positively associated with an increased risk of both ED 14 and, 13,21,35 and it has been suggested that vascular pathology may contribute to. 36 However, we controlled for these variables in our models. The sensitivity analyses excluding men with cardiovascular diseases or obesity generated similar significant results. Strengths of the current study include a large sample size, which enable us to obtain a relatively stable estimate for the associations, and use of standardized questionnaire to assess. Although we controlled a set of potential confounders in our models, a possibility of residual confounding cannot be excluded. The cross-sectional design of our study precludes conclusions regarding direction or causality of the observed associations. Further we assessed erectile function with a single question, which inevitably leads to some degree of misclassification for ED. However, in a validation study including 137 men aged y who participated in Massachusetts Male Aging Study, 37 erectile dysfunction measured by a self-reported single question, which is very similar to our question, were strongly correlated to (Spearman r = 0.80) the results of an independent urologic examination, which composed of four major components: a physical examination; detailed sexual history; medical history; and psychosocial history. Receiver operating curve analysis showed that the self-reported ED accurately predicts the clinician-diagnosed ED (area under the curve = 0.89). 37 Although we identified cases by use of the standard criteria of diagnosis, there is still a possibility that some -like symptoms which could be misclassified as. 38,39 We therefore excluded men with diabetes and arthritis in our primary analysis. Although we cannot exclude other two most common mimics, positional discomfort and leg cramps, 39 there has been no evidence that these two conditions are associated with ED. This misclassification may lead to an attenuation of the associations between and ED. We also conducted several sensitivity analyses by excluding men heart disease, hypertension, use of antidepressants and found similar significant results, suggesting the robustness of our findings. In conclusion, we found that men with had a higher likelihood of concurrent ED and the magnitude of the observed association was increased with a higher frequency of the restless leg symptoms. This finding indirectly supports a role of dopamine in. Further epidemiological studies are warranted SLEEP, Vol. 33, No. 1, to clarify the temporal relationship between and ED and to explore the biological mechanisms underlying this association. acknowledgments Finding/Support: The study was supported by NIH/NINDS grant R01 NS A2. None of the sponsors participated in the design of study or in the collection, analysis, or interpretation of the data. disclosure statement This was not an industry supported study. The authors have indicated no financial conflicts of interest REFERENCES 1. Kushida CA. Clinical presentation, diagnosis, and quality of life issues in restless legs syndrome. Am J Med. 2007;120:S4-S12 2. Allen RP, Picchietti D, Hening WA et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003;4: Allen RP. Controversies and challenges in defining the etiology and pathophysiology of restless legs syndrome. Am J Med. 2007;120:S Conti CF, de Oliveira MM, Andriolo RB et al. Levodopa for idiopathic restless legs syndrome: Evidence-based review. Mov Disord McCormack PL, Siddiqui MA. Pramipexole: in restless legs syndrome. CNS Drugs. 2007;21: Oertel WH, Benes H, Bodenschatz R et al. Efficacy of cabergoline in restless legs syndrome: a placebo-controlled study with polysomnography (CATOR). Neurology. 2006;67: Trenkwalder C. The weight of evidence for ropinirole in restless legs syndrome. Eur J Neurol. 2006;13 Suppl 3: Winkelmann J, Schadrack J, Wetter TC et al. opioid Opioid and dopamine antagonist drug challenges in untreated restless legs syndrome patients. Sleep Med. 2001;2: Montplaisir J, Lorrain D, Godbout R. Restless legs syndrome and periodic leg movements in sleep: the primary role of dopaminergic mechanism. Eur Neurol. 1991;31: Argiolas A, Melis MR. Central control of penile erection: role of the paraventricular nucleus of the hypothalamus. Prog Neurobiol. 2005;76: Papatsoris AG, Deliveliotis C, Singer C, Papapetropoulos S. Erectile dysfunction in Parkinson s disease. Urology. 2006;67: Gao X, Chen H, Schwarzschild MA et al. Erectile function and risk of Parkinson s disease. Am J Epidemiol. 2007;166: Gao X, Schwarzschild MA, Wang H, Ascherio A. Obesity and restless legs syndrome in men and women. Neurology. 2009;72: Bacon CG, Mittleman MA, Kawachi I et al. Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann Intern Med. 2003;139: Kawachi I, Colditz GA, Ascherio A et al. Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation. 1994;89: Albert CM, Chae CU, Rexrode KM et al. Phobic anxiety and risk of coronary heart disease and sudden cardiac death among women. Circulation. 2005;111: Wyllie MG. The underlying pathophysiology and causes of erectile dysfunction. Clin Cornerstone. 2005;7: Winkelmann J, Prager M, Lieb R et al. Anxietas tibiarum. Depression and anxiety disorders in patients with restless legs syndrome. J Neurol. 2005;252: Sevim S, Dogu O, Kaleagasi H et al. Correlation of anxiety and depression symptoms in patients with restless legs syndrome: a population based survey. J Neurol Neurosurg Psychiatry. 2004;75: Allen RP, Walters AS, Montplaisir J et al. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med. 2005;165: Winkelman JW, Shahar E, Sharief I, Gottlieb DJ. association Association of restless legs syndrome and cardiovascular disease in the Sleep Heart Health Study. Neurology. 2008;70:35-42

5 22. Tison F, Crochard A, Leger D et al. Epidemiology of restless legs syndrome in French adults: a nationwide survey: the INSTANT Study. Neurology. 2005;65: Ulfberg J, Nystrom B, Carter N, Edling C. Prevalence of restless legs syndrome among men aged 18 to 64 years: an association with somatic disease and neuropsychiatric symptoms. Mov Disord. 2001;16: Dula E, Bukofzer S, Perdok R, George M; Apomorphine SL Study Group. Double-blind, crossover comparison of 3 mg apomorphine SL with placebo and with 4 mg apomorphine SL in male erectile dysfunction. Eur Urol. 2001;39: Horita H, Sato Y, Adachi H et al. Effects of levodopa on nocturnal penile tumescence: a preliminary study. J Androl. 1998;19: Melis MR, Melis T, Cocco C et al. Oxytocin oxytocin injected into the ventral tegmental area induces penile erection and increases extracellular dopamine in the nucleus accumbens and paraventricular nucleus of the hypothalamus of male rats. Eur J Neurosci. 2007;26: Zhao H, Zhu W, Pan T et al. Spinal cord dopamine receptor expression and function in mice with 6-OHDA lesion of the A11 nucleus and dietary iron deprivation. J Neurosci Res. 2007;85: Winkelmann J, Schormair B, Lichtner P et al. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet. 2007;39: Rees PM, Fowler CJ, Maas CP. Sexual function in men and women with neurological disorders. Lancet. 2007;369: Hirshkowitz M, Karacan I, Arcasoy MO et al. The prevalence of periodic limb movements during sleep in men with erectile dysfunction. Biol Psychiatry. 1989;26: Jankowski JT, Seftel AD, Strohl KP. Erectile dysfunction and sleep related disorders. J Urol. 2008;179: Mann K, Pankok J, Connemann B et al. Sleep investigations in erectile dysfunction. J Psychiatr Res. 2005;39: Soukhova-O Hare GK, Shah ZA, Lei Z et al. Erectile dysfunction in a murine model of sleep apnea. Am J Respir Crit Care Med. 2008;178: Verratti V, Di Giulio C, Berardinelli F et al. The role of hypoxia in erectile dysfunction mechanisms. Int J Impot Res. 2007;19: Walters AS, Rye DB. Review of the relationship of restless legs syndrome and periodic limb movements in sleep to hypertension, heart disease, and stroke. Sleep. 2009;32: Rajaram SS, Shanahan J, Ash C et al. Enhanced external counter pulsation (EECP) as a novel treatment for restless legs syndrome (): a preliminary test of the vascular neurologic hypothesis for. Sleep Med. 2005;6: O Donnell AB, Araujo AB, Goldstein I, McKinlay JB. The validity of a single-question self-report of erectile dysfunction. Results from the Massachusetts Male Aging Study. J Gen Intern Med. 2005;20: Pwewe W, Stocchi F. Is restless legs syndrome over diagnosed? Moving Along. 2008;12: Hening WA, Allen RP, Washburn M et al. The four diagnostic criteria for Restless Legs Syndrome are unable to exclude confounding conditions ( mimics ). Sleep Med SLEEP, Vol. 33, No. 1,